Allogeneic versus autologous bone marrow transplantation versus chemotherapy for treatment of acute myeloid leukemia in first complete remission (BGM 84 and BGMT 87 studies). The BGMT Group.
Reiffers
J
J
Stoppa
A M
AM
Rigal-Huguet
F
F
Michallet
M
M
Marit
G
G
Gastaut
J A
JA
Attal
M
M
Corront
B
B
Broustet
A
A
Hollard
D
D
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D008875:Middle Aged; D011446:Prospective Studies; D012074:Remission Induction; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D003561:Cytarabine; D003630:Daunorubicin